Origin of the collaboration
The project was born thanks to the collaboration between Professor Claudio Tiribelli and Professor Richard Wennberg. Their goal was to find a simple solution to eradicate Kernicterus, a preventable disease that affects thousands of newborns worldwide.
With over 30 years of experience in clinical and basic bilirubin research, they were able to propose a strategy that could end this scourge.
From their analysis emerged that most cases of Kernicterus are caused by late diagnosis of jaundice, failure to evaluate risk factors and failure to monitor infants after discharge.
In response to these deficiencies, Professor Tiribelli and Professor Wennberg committed themselves to design a quick and portable diagnostic system that could measure total bilirubin concentration in new-born’s blood.
Once the first steps of the design were defined, Dr Carlos Coda Zabetta joined the team and became responsible for the development of the device. Now all that was left was a Technical Affairs Manager and that was when Dr Chiara Greco came into play.
At last, the Bilistick® System as we all know and love was born.

Our team

Claudio Tiribelli
Bilimetrix President and Scientific Director of the Italian Fegato-Onlus Foundation.
With more than 40 years of experience as Medical Doctor, he specialised on the physiological and pathological aspects of the liver with particular interest in bilirubin toxicity in the central nervous system.
Coordinator of numerous international scientific projects related to neonatal jaundice and brain damage caused by bilirubin.


Diego Sardon
CEO of Bilimetrix and Experienced Founder with a demonstrated history of working in the information technology and services industry.
Strong entrepreneurship professional skilled in Business Intelligence, Data Science & Data Health.


Diego Sardon
CEO of Bilimetrix and Experienced Founder with a demonstrated history of working in the information technology and services industry.
Strong entrepreneurship professional skilled in Business Intelligence, Data Science & Data Health.

Carlos Coda Zabetta
After graduating in Argentina in Biotechnology, in 2009 he came to Italy to get the Ph.D. in Molecular Biomedicine at the University of Trieste, focusing on the study of bilirubin toxicity mechanisms in neuronal cell models.
In 2011, he became responsible for the development of the Bilistick® System. Since 2014 he is the Chief Technical Officer (CTO) of Bilimetrix and is responsible for the coordination of research projects in different countries around the world.

I made it!”.

Chiara Greco
She graduated as a Biomedical Laboratory Technician and in 2015 she obtained her Master’s Degree in Science Diagnostic Techniques at the University of Ferrara.
Today she covers the role of Quality Responsible for Bilimetrix.




Chiara Greco
She graduated as a Biomedical Laboratory Technician and in 2015 she obtained her Master’s Degree in Science Diagnostic Techniques at the University of Ferrara.
Today she covers the role of Quality Responsible for Bilimetrix.

